Sources & Uses of funds

Glaxosmithkline Pharmaceuticals Ltd. Dec 2004 Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009
Rs. Crore (Non-Annualised) 12 mths 12 mths 12 mths 12 mths 12 mths 12 mths
-
Sources of funds
Internal sources 210.59 102.26 259.59 177.61 192.68 222.68
Retained profits 206.28 96.39 246.12 166.2 180.17 218.05
Depreciation 4.31 5.87 13.47 11.41 12.51 4.63

External sources 476.73 158.57 209.29 315 323.71 205.03

Fresh capital 50.49 -72.05 0 0 0 0
Share premium reserves 37.65 -69.43 0 0 0 0
Borrowings 0.98 1.01 0.69 0.23 -0.12 -0.23
Bank/Fin. Inst. borrowings 0 0 0 0 0 0
Debentures & bonds 0 0 0 0 0 0
Borrowings from corporate bodies 0 0 0 0 0 0
Borrowings from group/associated cos 0 0 0 0 0 0
Foreign borrowings 0 0 0 0 0 0
Loan from promoters/directors 0 0 0 0 0 0
Other borrowings 0.98 1.01 0.69 0.23 -0.12 -0.23
Current liabilities & provisions 425.26 229.61 208.6 314.77 323.83 205.26
Sundry creditors 11.8 33.37 -6.83 -4.33 25.36 42.93
Deferred tax liability 0.27 -3.7 -0.83 -0.76 -0.71 -1.52

Uses of funds
Gross fixed assets 0.4 9.69 9.08 9.86 19.95 18.45
Capital work-in-progress 0.46 10.86 -6.71 -3.23 4.52 11.41
Investments 367.72 136.21 226.37 193.91 -581.45 -560.96
Investment in group cos. 0 0 0 0 0 0
Current assets 304.37 130.02 238.59 293.31 1068.44 955.12
Inventories 25.61 -8.38 22.83 -34.99 22.42 24.64
Total receivables 7.66 -1.51 4.16 -28.43 53.96 -12.66
Sundry debtors 8.95 -8.67 -6.94 -22.68 20.17 -4.21
Loans & advances 0.22 10 0 -10.04 0.28 -0.35
Loans & advances to group & associated cos 0 0 0 0 0.31 -0.31
Expenses paid in advance 266.91 145.76 224.1 246.81 240.23 177.43
Cash & bank balance 3.97 -15.85 -12.5 119.96 751.55 766.06
Deferred tax assets 15.1 -18.79 -5.99 -5.23 8.74 13.58

Total sources/uses 687.59 257.13 468.05 491.85 515.68 426.19